跳至主要内容
临床试验/NCT01193543
NCT01193543已完成2 期

Effect of Calanus Oli on Intra-abdominal Fat, Glucose Tolerance and Lipids in Man

University of Tromso2 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
117
试验地点
2
主要终点
Intra-abdominal fat as measured with CT scan

研究概览

简要总结

Preliminary studies in rats and mice indicate that calanus oil reduce accumulation of intra-abdominal fat. Pilot studies in humans have shown no adverse effects. In the present study 120 subjects, males and females, 20-65 years old, BMI 25-30 kg/m2 will be included and given calanus oli 1 g twice daily versus placebo for 1 year. The hypothesis is that calanus oil will reduce intra-abdominal fat, improve glucose tolerance and lipid profile.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body Mass Index (BMI) 25-30 kg/m2
  • age 20-65 years

排除标准

  • coronary heart disease last 12 months
  • unstable angina pectoris
  • cancer diagnosed the last 5 years
  • use of lipid lowering drugs
  • seafood allergy

结局指标

主要结局

Intra-abdominal fat as measured with CT scan

时间窗: at the end of 12 months intervention

次要结局

  • oral glucose tolerance test(at the end of 12 months intervention)
  • lipid status(at the end of 12 months intervention)
  • systolic and diastolic blood pressure(at the end of 12 months intervention)
  • markers of inflammation - C-reactive protein (CRP)(at the end of 12 months intervention)
  • body weight(at the end of 12 months intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Effect of Calanus Oli on Intra-abdominal Fat,... | 临床试验